RxDoctor Payments Data

Andrea Apolo

Internal Medicine · Bethesda, MDNPI 1902059124

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.0% of the total across 15 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Pfizer at 34.9% of the total.

$711in general payments, 2019–2025

Across 15 payments — averaging $47.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$248
  • E.r. Squibb & Sons, L.L.C.$178
  • AbbVie$136
  • Exelixis Inc.$77
  • Jazz Pharmaceuticals Inc.$50
  • Amgen$21
$4,789,605in research payments, 2019–2025

Across 25 payments — averaging $191,584 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$4.4M
  • Gilead$220K
  • Astellas US Technologies$84K
  • Jazz Pharmaceuticals Inc.$77K

What the payments were for

  • Food & beverage$66193%
  • Education$507%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$711 in reported general payments places this provider in the 65th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland

Other internal medicine in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →